Clinical Trials Directory

Trials / Completed

CompletedNCT01420822

Special Drug Use Investigation for ALLERMIST (Long Term)

Status
Completed
Phase
Study type
Observational
Enrollment
500 (actual)
Sponsor
GlaxoSmithKline · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This post-marketing surveillance study is to investigate possible problems or questions in safety and efficacy of ALLERMIST Nasal Spray for long-term use in Japanese subjects with allergic rhinitis under the conditions of actual practical use.

Conditions

Interventions

TypeNameDescription
DRUGFluticasoneCollection of safety data

Timeline

Start date
2010-12-01
Primary completion
2014-08-01
Completion
2014-08-01
First posted
2011-08-22
Last updated
2015-03-27

Source: ClinicalTrials.gov record NCT01420822. Inclusion in this directory is not an endorsement.